Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Leukemia & Lymphoma|September 24, 1999
The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapyJ Mehta, R Powles, J Treleaven, et al.Bone Marrow Transplantation|July 3, 2003
Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?J Mehta, R Powles, B Sirohi, et al.Bone Marrow Transplantation|May 17, 2005
An elective single autograft with high-dose melphalan: single-center study of 451 patientsB Sirohi, R Powles, J Mehta, et al.Bone Marrow Transplantation|May 29, 1998
Secondary leukaemia characterised by monosomy 7 occurring post-autologous stem cell transplantation for AMLK P Rege, S L Janes, R Saso, et al.British Journal of Haematology|December 1, 1995
Absence of N-RAS point mutations in peripheral blood cells of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinureaJ R White, K M Josten, R Chopra, et al.Bone Marrow Transplantation|May 9, 2000
Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patientsR Powles, B Sirohi, S Kulkarni, et al.Bone Marrow Transplantation|August 11, 2001
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteriaB Sirohi, R Powles, S Kulkarni, et al.British Journal of Cancer|August 7, 2001
Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myelomaB Sirohi, R Powles, S Kulkarni, et al.Bone Marrow Transplantation|April 15, 2008
The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patientsB Sirohi, R Powles, J Treleaven, et al.British Journal of Cancer|July 7, 2000
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinomaR Saso, S Kulkarni, P Mitchell, et al.Pageof 4